Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
International Business Machines Co. stock logo
IBM
International Business Machines
$167.13
-1.5%
$177.70
$127.46
$199.18
$153.53B0.744.73 million shs4.19 million shs
NVIDIA Co. stock logo
NVDA
NVIDIA
$1,148.25
+0.8%
$906.58
$373.56
$1,154.92
$2.82T1.7550.05 million shs55.57 million shs
RH stock logo
RH
RH
$252.49
+0.7%
$274.26
$207.26
$406.38
$4.60B2.54670,273 shs526,644 shs
Roche Holding AG stock logo
RHHBY
Roche
$31.33
+0.1%
$30.96
$29.20
$40.48
$213.78B0.412.55 million shs1.89 million shs
Roche Holding AG stock logo
RHHVF
Roche
$251.92
+0.2%
$247.23
$233.12
$323.78
N/AN/A8,338 shs1,083 shs
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$8.58
-4.6%
$8.90
$4.97
$16.75
$2.04B0.856.21 million shs5.73 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
International Business Machines Co. stock logo
IBM
International Business Machines
-1.52%-3.78%-0.23%-9.55%+29.09%
NVIDIA Co. stock logo
NVDA
NVIDIA
+0.81%+20.93%+30.84%+45.14%+186.27%
RH stock logo
RH
RH
+0.65%-0.73%-1.28%-7.98%+0.33%
Roche Holding AG stock logo
RHHBY
Roche
+0.10%-1.07%+3.30%-4.28%-21.38%
Roche Holding AG stock logo
RHHVF
Roche
+0.16%+0.23%+4.91%-3.29%-21.30%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-4.56%-8.33%+4.63%-36.26%-2.72%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
International Business Machines Co. stock logo
IBM
International Business Machines
4.0718 of 5 stars
2.13.04.23.52.00.81.9
NVIDIA Co. stock logo
NVDA
NVIDIA
4.6066 of 5 stars
2.53.01.73.03.12.53.1
RH stock logo
RH
RH
4.8442 of 5 stars
4.14.00.01.22.44.22.5
Roche Holding AG stock logo
RHHBY
Roche
2.494 of 5 stars
3.03.01.70.01.60.01.3
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
1.7068 of 5 stars
3.31.00.00.02.13.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
International Business Machines Co. stock logo
IBM
International Business Machines
2.14
Hold$181.298.47% Upside
NVIDIA Co. stock logo
NVDA
NVIDIA
2.93
Moderate Buy$1,123.49-2.16% Downside
RH stock logo
RH
RH
2.29
Hold$332.1531.55% Upside
Roche Holding AG stock logo
RHHBY
Roche
2.00
Hold$40.0027.67% Upside
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
2.50
Moderate Buy$14.3367.06% Upside

Current Analyst Ratings

Latest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/24/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$1,025.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$1,000.00 ➝ $1,200.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,030.00 ➝ $1,260.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$1,100.00 ➝ $1,100.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$1,150.00 ➝ $1,250.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$1,200.00 ➝ $1,400.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,150.00 ➝ $1,200.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,000.00 ➝ $1,350.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$1,000.00 ➝ $1,160.00
5/23/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1,200.00 ➝ $1,350.00
5/22/2024
International Business Machines Co. stock logo
IBM
International Business Machines
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$200.00
(Data available from 5/30/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
International Business Machines Co. stock logo
IBM
International Business Machines
$62.07B2.47$14.21 per share11.76$25.40 per share6.58
NVIDIA Co. stock logo
NVDA
NVIDIA
$60.92B46.36$13.38 per share85.82$19.98 per share57.47
RH stock logo
RH
RH
$3.03B1.53$19.03 per share13.27($16.16) per share-15.62
Roche Holding AG stock logo
RHHBY
Roche
$65.37B3.27$3.08 per share10.17$4.91 per share6.38
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/AN/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$44.58M45.74N/AN/A$1.69 per share5.08

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
International Business Machines Co. stock logo
IBM
International Business Machines
$7.50B$8.8318.9316.194.2113.18%40.21%6.88%7/24/2024 (Confirmed)
NVIDIA Co. stock logo
NVDA
NVIDIA
$29.76B$17.1067.1541.771.2353.40%110.60%68.60%8/28/2024 (Estimated)
RH stock logo
RH
RH
$127.56M$5.5745.3316.382.834.21%-777.61%3.29%5/30/2024 (Estimated)
Roche Holding AG stock logo
RHHBY
Roche
$12.81BN/A0.0011.787.07N/AN/AN/A7/23/2024 (Estimated)
Roche Holding AG stock logo
RHHVF
Roche
N/A$10.8123.30N/AN/AN/AN/A7/23/2024 (Estimated)
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$328.07M-$1.60N/AN/AN/A-765.90%-79.96%-56.45%8/13/2024 (Estimated)

Latest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2024N/A
International Business Machines Co. stock logo
IBM
International Business Machines
$2.17N/A-$2.17N/AN/AN/A
5/22/2024Q1 2
NVIDIA Co. stock logo
NVDA
NVIDIA
$5.14$6.12+$0.98$5.62$24.59 billion$26.04 billion      
5/9/2024Q1 2024
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
-$0.43-$0.39+$0.04-$0.39$11.10 million$13.80 million    
4/30/2024Q1 24
International Business Machines Co. stock logo
IBM
International Business Machines
$1.59$1.68+$0.09$1.64$14.53 billion$14.46 billion      
3/27/2024Q4 2024
RH stock logo
RH
RH
$1.71$0.72-$0.99$0.87$777.50 million$738.26 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
International Business Machines Co. stock logo
IBM
International Business Machines
$6.684.00%+0.61%75.65%29 Years
NVIDIA Co. stock logo
NVDA
NVIDIA
$0.160.01%N/A0.94%N/A
RH stock logo
RH
RH
N/AN/AN/AN/AN/A
Roche Holding AG stock logo
RHHBY
Roche
$0.842.68%N/AN/AN/A
Roche Holding AG stock logo
RHHVF
Roche
$7.803.10%N/A72.16%N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/AN/AN/AN/AN/A

Latest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
quarterly$0.100.04%6/11/20246/11/20246/28/2024
4/30/2024
International Business Machines Co. stock logo
IBM
International Business Machines
quarterly$1.674.02%5/9/20245/10/20246/10/2024
5/17/2024
NVIDIA Co. stock logo
NVDA
NVIDIA
Quarterly$0.040.02%5/29/20245/29/20246/4/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
International Business Machines Co. stock logo
IBM
International Business Machines
2.32
1.13
1.09
NVIDIA Co. stock logo
NVDA
NVIDIA
0.17
3.53
3.14
RH stock logo
RH
RH
N/A
1.26
0.40
Roche Holding AG stock logo
RHHBY
Roche
0.75
1.35
1.04
Roche Holding AG stock logo
RHHVF
Roche
N/AN/AN/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
N/A
4.65
4.65

Ownership

Institutional Ownership

CompanyInstitutional Ownership
International Business Machines Co. stock logo
IBM
International Business Machines
58.96%
NVIDIA Co. stock logo
NVDA
NVIDIA
65.27%
RH stock logo
RH
RH
90.17%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
29.01%
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
89.06%

Insider Ownership

CompanyInsider Ownership
International Business Machines Co. stock logo
IBM
International Business Machines
0.07%
NVIDIA Co. stock logo
NVDA
NVIDIA
4.23%
RH stock logo
RH
RH
28.10%
Roche Holding AG stock logo
RHHBY
Roche
N/A
Roche Holding AG stock logo
RHHVF
Roche
N/A
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
15.75%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
International Business Machines Co. stock logo
IBM
International Business Machines
305,300918.60 million917.96 millionOptionable
NVIDIA Co. stock logo
NVDA
NVIDIA
29,6002.46 billion2.36 billionOptionable
RH stock logo
RH
RH
5,96018.34 million13.19 millionOptionable
Roche Holding AG stock logo
RHHBY
Roche
103,6056.83 billionN/ANot Optionable
Roche Holding AG stock logo
RHHVF
Roche
103,605N/AN/ANot Optionable
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
500237.66 million200.23 millionOptionable

RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Headlines

Recent News About These Companies

2 Stocks That Could 10x by 2035

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

International Business Machines logo

International Business Machines

NYSE:IBM
International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.
NVIDIA logo

NVIDIA

NASDAQ:NVDA
NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.
RH logo

RH

NYSE:RH
RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.
Roche logo

Roche

OTCMKTS:RHHBY
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Roche logo

Roche

OTCMKTS:RHHVF
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

NASDAQ:RXRX
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.